March 06, 2015 at 01:45PM Biosimilars: More Treatment Options Are on the Way

The Food and Drug Administration (FDA) is approving Zarxio (filgrastim-sndz), the first biosimilar product (or biosimilar), and expects to approve others in the months ahead. What are biosimilars? How will they affect patient treatment?



via FDA Consumer Health Information Updates http://ift.tt/1FjXckk